All
The Unnamed Nurse who Saved My Life During Breast Cancer
I’ll never forget the unnamed nurse who stayed calm and gentle while treating me during a dangerous post-surgery infection that could have ended my life.
Acoustic Cluster Therapy Shows Benefit in Colorectal Liver Metastases
Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial.
Prostate Cancer Treatment Options: Common Questions in Focal Therapy, Surgery
Dr. Kelly Stratton answered the most frequently asked questions in prostate cancer regarding localized prostate cancer care, including surgery and focal therapy.
With Cancer in Remission, What Is the New Normal for Patients?
CURE spoke with experts about what life is like for patients in the survivorship care period.
Younger Patients With Lung Cancer Often Have Targetable Biomarkers
Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more personalized and effective treatment.
Facing Cancer as an AYA and Navigating Fertility Preservation Choices
Carly Stafford Dixon, discusses how she approached fertility preservation after her diagnosis of primary mediastinal b-cell lymphoma, a rare blood cancer.
What Patients Should Know About a Melanoma Diagnosis
Melanoma care varies by stage, with early cases being treated with surgery, whereas advanced disease often requires immunotherapy or targeted therapy.
Reflecting on my Son's Graduation as a Previvor
As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.
Answers to Frequently Asked Questions About Prostate Cancer Risk, Treatment
Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options.
First Patient Dosed With CX-801 Plus Keytruda in Metastatic Melanoma
The first patient has received CX-801 plus Keytruda in a phase 1 trial for metastatic melanoma, aiming to assess safety and early antitumor activity.
Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.
Fatigue, Sleep and Urinary Symptoms Affect Cognition in Prostate Cancer
Managing fatigue, sleep, urinary symptoms and depression is key to improving cognitive function in those receiving radiation therapy for prostate cancer.
Providing Care and Listening With Compassion During Cancer
Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC
Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.
Cancer Didn’t Break Me; It Revealed My Strength
I’m a single mom with chronic lymphocytic leukemia sharing how cancer tested me but revealed my resilience, hardship and the power of speaking up.
EPA Deregulation Means More Air Pollution and More Cancer Deaths
Recently, the American Lung Association released the 2025 “State of the Air” report.
2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.
Enclosed is the 2025 Quarter 1 – COA Patient Advocacy Network News Bulletin.
Understanding Unique Treatment Options Across Bladder Cancer Care
Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease stage and type.
Brain Cancer Awareness Month Highlights Advances in Radiation Therapy
Dr. Ranjit S. Bindra discusses recent advancements for the treatment of patients with primary brain tumors during Brain Cancer Awareness Month.
Tips for Combating Lymphedema After Breast Cancer
With proper precautions, international travel and safeguarding an arm with lymphedema are possible. Always prioritize your health and seek medical advice.
Samuraciclib Therapy Combo Shows Responses in HR+ Advanced Breast Cancer
Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy.
Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer
Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.
Preparing For Survivorship After Lymphoma Treatment in AYA Patients
Dr. Kara Kelly discusses specific long-term health considerations that AYA survivors of lymphoma should be aware of to best prepare for survivorship.
Bladder Cancer Awareness Month Highlights the Importance of Early Detection
Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.
Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer
The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.
Finding Comfort in Teddy Bears Throughout My Experience With CLL
As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing their quiet presence myself.
Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC
The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.
Efti Plus Keytruda With Chemo Shows High Response in NSCLC Subset
Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, outperforming historical data.
Lumakras Plus Vectibix Shows Potential in KRAS G12C Colorectal Cancer
Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though not statistically significant.
